Alternative approaches to measuring value: an update on innovative methods in the context of the United States Medicare drug price negotiation program-Reference-Cited by-同舟云学术

Alternative approaches to measuring value: an update on innovative methods in the context of the United States Medicare drug price negotiation program

Published:2023-11-17 Issue:2 Volume:24 Page:171-180
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

DiStefano Michael J.¹,Zemplenyi Antal¹²,Anderson Kelly E.¹,Mendola Nicholas D.¹,Nair Kavita V.³,McQueen Robert Brett¹

Affiliation:

1. Center for Pharmaceutical Outcomes Research, Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, USA

2. Center for Health Technology Assessment and Pharmacoeconomics Research, Faculty of Pharmacy, University of Pécs, Pécs, Hungary

3. Department of Neurology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2023.2283584

Reference32 articles.

1. Inflation Reduction Act 2022. [cited 2022 Oct 6]. https://www.congress.gov/bill/117th-congress/house-bill/5376/text

2. Pharmaceutical Price and Spending Controls in France: Lessons for the United States

3. German Pharmaceutical Pricing: Lessons for the United States

4. Seshamani M. Medicare drug price negotiation program: revised guidance implementation of sections 1191 – 1198 of the Social security Act for initial price applicability Year 2026. [cited 2023 Aug 14].

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expert review of pharmacoeconomics and outcomes research: high impact articles from 2023;Expert Review of Pharmacoeconomics & Outcomes Research;2024-04-09